Management of Diarrhea Caused by Linaclotide

Understanding the Mechanism

Diarrhea is the most common adverse effect of linaclotide, occurring because it is a guanylate cyclase-C agonist that increases intestinal fluid secretion and accelerates gastrointestinal transit 1

For patients taking linaclotide, the American Gastroenterological Association recommends taking the medication on an empty stomach at least 30 minutes before the first meal of the day to potentially reduce diarrhea severity 3
The National Comprehensive Cancer Network recommends implementing a bland diet or BRAT diet and ensuring adequate hydration and electrolyte replacement for patients with diarrhea caused by linaclotide 4, 2
The American College of Gastroenterology suggests avoiding lactose-containing products and high-osmolar dietary supplements for patients with diarrhea caused by linaclotide 5, 2

For patients with severe diarrhea, the European Society for Medical Oncology recommends considering adding loperamide, with an initial dose of 4 mg followed by 2 mg every 4 hours, not exceeding 16 mg/day 2, 5
If diarrhea persists for more than 48 hours on high-dose loperamide, the American Society of Clinical Oncology suggests considering second-line agents such as octreotide 5

The American Gastroenterological Association recommends considering switching to lubiprostone for patients with intolerable diarrhea caused by linaclotide, as it is less likely to cause diarrhea but may cause nausea instead 1, 3